The AI in Business Podcast Scaling Drug Manufacturing from Clinical Trials to Commercial Production - with Shreyas Becker of Sanofi
May 29, 2025
Shreyas Becker, Head of AI & Data Products at Sanofi, dives deep into the intersection of AI and life sciences. He discusses how AI tools are revolutionizing supply chains, especially during geopolitical upheaval. Shreyas highlights AI's role in optimizing drug manufacturing, identifying bottlenecks, and enhancing decision-making. He also shares insights from pandemic-driven innovations and underscores the essential balance between AI automation and human expertise in ensuring reliable medication delivery.
AI Snips
Chapters
Transcript
Episode notes
AI's Role in Reliable Drug Supply
- AI ensures reliable, predictable supply of life-saving drugs by aligning teams with complex data.
- It helps focus on critical bottlenecks a human mind cannot easily discern, improving supply chain resilience.
Crisis Spurs Supply Chain Redesign
- Pandemic-era AI system training offered a chance to redesign supply chains rather than only optimize.
- Shocks like pandemics enable leapfrogging small gains and create opportunities for system overhaul.
Manufacturing Challenges and AI Reasoning
- Manufacturing and supply chain challenges differ; sourcing raw materials is affected by geopolitical changes.
- Modern AI's reasoning ability enables it to handle unseen edge cases and redesign systems holistically.